Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45d685b2e44955a6b099f9b62cdda6fe |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57eeb8bf02a73292ebf051a2d0614134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9cddf17035ec9d3f0800388fa1228b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35b90fded506577b5610b2b9a5379415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2892f0bfae2ad9ec01313a0571e8269 |
publicationDate |
2021-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2016274599-B2 |
titleOfInvention |
Formulations for small intestinal delivery of RSV and norovirus antigens |
abstract |
Provided herein are compositions and methods for generating an immunogenic response in humans. Further provided are methods for designing such compositions, e.g., for vaccines. |
priorityDate |
2015-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |